Teva seeks to reinvent itself as branded drug developer
After years of shrinking revenue, new CEO Richard Francis is switching the emphasis to innovation. "Globes" looks at Teva's drug development pipeline.
Source: globes.co.il
Page 16 - Umer Raffat News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Umer Raffat. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Umer Raffat Today - Breaking & Trending Today
Obesity Pills: Race to develop weight-loss pills has some drugmakers falling behind
Weight Loss Pills: Novo and Lilly's experimental obesity pills helped people lose about 15% of body weight, similar to weight-loss shots on the market already, according to findings presented
Source: business-standard.com
Pfizer picks GLP-1 candidate in race for Ozempic-like weight-loss pill
Pfizer will move ahead with a pill version of a weight-loss drug as competition heats up for an oral medication that can rival Ozempic and other GLP-1 drugs.
Source: washingtonpost.com
Pfizer punts on one oral GLP-1 candidate, advances another
Analysts have been less than impressed with the surviving pill, danuglipron, due to a number of commercial uncertainties.
Source: mmm-online.com
Dice Stock Catapults To Record High On $2.4 Billion Eli Lilly Buyout
Dice stock skyrocketed Tuesday after Eli Lilly pledged to buy the immunology-focused biotech company for $2.4 billion.
Source: investors.com